Basilea Pharmaceutica AG (BSLN) — Financial Flexibility Index
Basilea Pharmaceutica AG (BSLN) has a Financial Flexibility Index of 0.27x as of December 2025. Free cash flow of CHF41.33 Million (operating CF CHF39.03 Million minus capex CHF2.30 Million) represents 0% of total liabilities (CHF154.06 Million). Also explore Basilea Pharmaceutica AG net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Basilea Pharmaceutica AG Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Basilea Pharmaceutica AG across 24 annual periods. Check Basilea Pharmaceutica AG PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Basilea Pharmaceutica AG (2002–2025)
Year-by-year free cash flow to debt coverage for Basilea Pharmaceutica AG. For the full company profile including market capitalisation, see Basilea Pharmaceutica AG market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF64.71 Million | CHF62.09 Million | CHF154.06 Million | ▼ -2.4% |
| 2024 | 0.43x | CHF76.07 Million | CHF74.36 Million | CHF176.76 Million | ▲ +416.3% |
| 2023 | 0.08x | CHF15.28 Million | CHF14.24 Million | CHF183.29 Million | ▲ +94.4% |
| 2022 | 0.04x | CHF10.36 Million | CHF7.06 Million | CHF241.56 Million | ▲ +142.1% |
| 2021 | -0.10x | CHF-31.16 Million | CHF-32.02 Million | CHF305.87 Million | ▲ +34.8% |
| 2020 | -0.16x | CHF-51.87 Million | CHF-54.13 Million | CHF331.84 Million | ▲ +22.5% |
| 2019 | -0.20x | CHF-63.43 Million | CHF-63.84 Million | CHF314.43 Million | ▲ +10.8% |
| 2018 | -0.23x | CHF-78.79 Million | CHF-79.21 Million | CHF348.44 Million | ▼ -550.1% |
| 2017 | 0.05x | CHF19.73 Million | CHF19.01 Million | CHF392.61 Million | ▲ +124.4% |
| 2016 | -0.21x | CHF-74.61 Million | CHF-75.00 Million | CHF362.76 Million | ▼ -18.2% |
| 2015 | -0.17x | CHF-66.77 Million | CHF-67.78 Million | CHF383.88 Million | ▲ +50.6% |
| 2014 | -0.35x | CHF-70.21 Million | CHF-71.46 Million | CHF199.45 Million | ▼ -38.1% |
| 2013 | -0.26x | CHF-58.37 Million | CHF-59.47 Million | CHF228.88 Million | ▼ -146.0% |
| 2012 | 0.55x | CHF149.50 Million | CHF148.17 Million | CHF269.84 Million | ▲ +158.9% |
| 2011 | -0.94x | CHF-78.85 Million | CHF-82.38 Million | CHF83.82 Million | ▼ -192.7% |
| 2010 | 1.01x | CHF107.88 Million | CHF106.64 Million | CHF106.30 Million | ▲ +198.0% |
| 2009 | -1.04x | CHF-112.75 Million | CHF-114.51 Million | CHF108.88 Million | ▼ -9.0% |
| 2008 | -0.95x | CHF-121.95 Million | CHF-127.17 Million | CHF128.38 Million | ▼ -65.6% |
| 2007 | -0.57x | CHF-72.46 Million | CHF-78.99 Million | CHF126.34 Million | ▲ +26.5% |
| 2006 | -0.78x | CHF-70.84 Million | CHF-72.47 Million | CHF90.78 Million | ▼ -292.3% |
| 2005 | 0.41x | CHF35.58 Million | CHF34.38 Million | CHF87.69 Million | ▲ +113.5% |
| 2004 | -3.01x | CHF-63.76 Million | CHF-64.20 Million | CHF21.18 Million | ▼ -5.0% |
| 2003 | -2.87x | CHF-47.98 Million | CHF-52.42 Million | CHF16.73 Million | ▼ -74.3% |
| 2002 | -1.65x | CHF-41.35 Million | CHF-64.07 Million | CHF25.13 Million | — |